TheStreet lowered shares of USANA Health Sciences (NYSE:USNA) from a b rating to a c+ rating in a research report report published on Wednesday, TheStreetRatingsTable reports.

Separately, Zacks Investment Research downgraded USANA Health Sciences from a strong-buy rating to a hold rating in a research note on Wednesday, December 29th.

Shares of USANA Health Sciences stock opened at $88.23 on Wednesday. USANA Health Sciences has a one year low of $79.92 and a one year high of $107.85. The stock’s 50-day moving average is $98.62 and its 200 day moving average is $97.53. The firm has a market cap of $1.72 billion, a price-to-earnings ratio of 13.47 and a beta of 0.85.

USANA Health Sciences (NYSE:USNA) last announced its earnings results on Monday, February 7th. The company reported $1.03 EPS for the quarter, missing the consensus estimate of $1.28 by ($0.25). USANA Health Sciences had a net margin of 11.05% and a return on equity of 32.68%. During the same period in the prior year, the business posted $1.87 EPS. On average, analysts predict that USANA Health Sciences will post 5.98 earnings per share for the current fiscal year.

In other news, COO Walter Noot sold 6,193 shares of the stock in a transaction that occurred on Thursday, December 16th. The stock was sold at an average price of $102.25, for a total value of $633,234.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Daniel A. Macuga sold 368 shares of the stock in a transaction that occurred on Wednesday, December 8th. The stock was sold at an average price of $100.86, for a total value of $37,116.48. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 7,130 shares of company stock worth $728,389. 0.21% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently modified their holdings of the stock. Altshuler Shaham Ltd increased its position in shares of USANA Health Sciences by 28.3% during the third quarter. Altshuler Shaham Ltd now owns 508 shares of the company’s stock valued at $47,000 after acquiring an additional 112 shares during the last quarter. Cornercap Investment Counsel Inc. grew its holdings in USANA Health Sciences by 0.9% during the third quarter. Cornercap Investment Counsel Inc. now owns 14,346 shares of the company’s stock valued at $1,323,000 after purchasing an additional 126 shares during the period. ProShare Advisors LLC grew its holdings in USANA Health Sciences by 4.9% during the second quarter. ProShare Advisors LLC now owns 3,609 shares of the company’s stock valued at $370,000 after purchasing an additional 167 shares during the period. Victory Capital Management Inc. grew its holdings in USANA Health Sciences by 4.9% during the third quarter. Victory Capital Management Inc. now owns 5,332 shares of the company’s stock valued at $492,000 after purchasing an additional 249 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in USANA Health Sciences by 2.8% during the third quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 9,104 shares of the company’s stock valued at $839,000 after purchasing an additional 252 shares during the period. 54.82% of the stock is owned by institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures nutritional, personal care and weight-management products. Its product line divided into four categories: Essentials, Optimizers, Foods, Personal Care and Skincare, and All Other. The Essentials Nutritionals category includes vitamin and mineral supplements that provide a foundation of advanced total body nutrition for every age group.

See Also